University of Louisville
Also known as: Brown Cancer Center, University of Louisville | Craig James McClain | Department of Medicine, University of Louisville | Director, Graduate Periodontics, University of Louisville | James Graham Brown Cancer | James Graham Brown Cancer Center at University of Louisville | James Graham Brown Cancer Center, Univeristy of Louisville | James Graham Brown Cancer Center- University of Louisville | James Graham Brown Cancer Center-University of Louisville | James Graham Brown Cancer Center, University of Louisville | James Graham Brown Cancer Center/ University of Louisville | James Graham Brown Cancer Center/University of Louisville | James Graham Brown Cancer Center-U of Louisville | Jessica M D'Amico | Jonathan M Towarnicki | Julio Ramirez | Kelly McMasters | Kenneth Palmer | Louisville Oncology Clinical Research Program | Louisville-PPRU | Olivia Cardenas-Trowers, M.D. | Rainer Lenhardt | Richard Eiferman, MD, PSC | Robert C. Martin | Robert F James, MD, FACS, FAANS | Sham Sunder Kakar | Tien Huey-Yuan | UL Health Brown Cancer Center Deputy Director, Health Affairs | U Louisville | University of Louisville | University of Louisville, Dept. of Pediatrics, Div. of Pediatric Emergency Medicine | University of Louisville, Division of Movement Disorders | University of Louisville Division of Neonatal Medicine | University of Louisville, James Graham Brown Cancer Center | University of Louisville/James Graham Brown Cancer Ctr. | University of Louisville, Kosairs Charities Pediatric Clinical Research Unit | University of Louisville, Louisville | University of Louisville, School of Dentistry | University of Louisville School of Medicine | University of Louisville School of Medicine Division of Plastic Surgery | University of Louisville, School of Nursing | University of Louisville, USA
Highest phase reached
Phase 4
First clinical trial
Aug 1, 1998Last known activity
Feb 6, 2026
Timeline
1790s
- Jan 1, 1798
University of Louisville— Founded
Drugs by trial phase (190 distinct, 169 trials)
Phase 4 (36 own, 0 via acquisition)
Phase 3 (24 own, 0 via acquisition)
Phase 2 (67 own, 0 via acquisition)
Phase 1 (33 own, 0 via acquisition)
Other trials (30 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adrenoleukodystrophy
- alpha-Mannosidosis
- alpha-Thalassemia
- Anemia
- Anemia, Diamond-Blackfan
- Anemia, Sickle Cell
- Aneurysm
- Apnea
- Asthma
- Atrial Fibrillation
- Atrophic Vaginitis
- Autism Spectrum Disorder
- Autistic Disorder
- Bacterial Infections
- Behavior, Addictive
- beta-Thalassemia
- Bipolar Disorder
- Blepharitis
- Brain Injuries
- Breakthrough Pain
- Bronchiolitis
- Burns
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Small Cell
- Cardiomyopathies
- Cardiovascular Diseases
- Child Development Disorders, Pervasive
- Cholangiocarcinoma
- Colitis
- Colitis, Ulcerative
- Colonic Neoplasms
- Communicable Diseases
- Constipation
- Coronary Artery Disease
- Coronary Disease
- Cystitis
- Cystitis, Interstitial
- Depression
- Depressive Disorder
- Dry Eye Syndromes
- Endometriosis
- Enuresis
- Esophagitis, Peptic
- Exanthema
- Fatty Liver
- Fatty Liver, Alcoholic
- Fibrosis
- Gastroesophageal Reflux
- Gastroparesis
- Glioblastoma
- Glioma
- Head and Neck Neoplasms
- Heart Failure
- Hemoglobinopathies
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis, Alcoholic
- Hepatorenal Syndrome
- Hypercapnia
- Hypothermia
- Idiopathic Pulmonary Fibrosis
- Infections
- Influenza, Human
- Intracranial Aneurysm
- Keratoconjunctivitis
- Keratoconjunctivitis Sicca
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukodystrophy, Globoid Cell
- Leukodystrophy, Metachromatic
- Lichen Planus
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Mannosidase Deficiency Diseases
- Medulloblastoma
- Melanoma
- Metabolic Diseases
- Mouth Neoplasms
- Mucopolysaccharidosis I
- Mucopolysaccharidosis II
- Mucopolysaccharidosis III
- Mucositis
- Multiple Myeloma
- Multiple Sclerosis
- Myocardial Ischemia
- Neonatal Abstinence Syndrome
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Neoplasms, Second Primary
- Neurobehavioral Manifestations
- Neuroblastoma
Recent trials (50)
- NCT07221214CollaboratorPhase 2Feb 6, 2026
- NCT07219888OfficialPhase 4Dec 1, 2025
- NCT07219888Sponsor investigatorPhase 4Dec 1, 2025
- NCT07219888Lead sponsorPhase 4Dec 1, 2025
- NCT07044726Lead sponsorPhase 4Jun 23, 2025
- NCT07044726OfficialPhase 4Jun 23, 2025
- NCT07044726Sponsor investigatorPhase 4Jun 23, 2025
- NCT06953674Sponsor investigatorPhase 3Jun 1, 2025
- NCT06953674Lead sponsorPhase 3Jun 1, 2025
- NCT06695585OfficialPhase 4Dec 1, 2024
- NCT06695585Lead sponsorPhase 4Dec 1, 2024
- NCT06695585Sponsor investigatorPhase 4Dec 1, 2024
- NCT06480760OfficialPhase 1/Phase 2Aug 1, 2024
- NCT06480760Sponsor investigatorPhase 1/Phase 2Aug 1, 2024
- NCT06480760Lead sponsorPhase 1/Phase 2Aug 1, 2024
Details
- Founded
- Louisville, KY, US Jan 1, 1798
- Last known activity
- Feb 6, 2026